Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EDEM2 anticorps (AA 22-300) (FITC)

EDEM2 Reactivité: Humain Hôte: Lapin Polyclonal FITC
N° du produit ABIN7151976
  • Antigène Voir toutes EDEM2 Anticorps
    EDEM2 (ER Degradation Enhancer, Mannosidase alpha-Like 2 (EDEM2))
    Épitope
    • 15
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 22-300
    Reactivité
    • 28
    • 1
    • 1
    Humain
    Hôte
    • 24
    • 4
    Lapin
    Clonalité
    • 25
    • 3
    Polyclonal
    Conjugué
    • 11
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp EDEM2 est conjugé à/à la FITC
    Application
    Veuillez nous consulter SVP
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human ER degradation-enhancing alpha-mannosidase-like protein 2 protein (22-300AA)
    Isotype
    IgG
    Top Product
    Discover our top product EDEM2 Anticorps primaire
  • Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    EDEM2 (ER Degradation Enhancer, Mannosidase alpha-Like 2 (EDEM2))
    Autre désignation
    EDEM2 (EDEM2 Produits)
    Synonymes
    anticorps C20orf31, anticorps C20orf49, anticorps bA4204.1, anticorps 9530090G24Rik, anticorps AI327354, anticorps RGD1303074, anticorps MGC88910, anticorps DKFZp459A0314, anticorps ER degradation enhancing alpha-mannosidase like protein 2, anticorps ER degradation enhancer, mannosidase alpha-like 2, anticorps EDEM2, anticorps Edem2, anticorps edem2
    Sujet

    Background: Initiates the endoplasmic reticulum-associated degradation (ERAD) that targets misfolded glycoproteins for degradation in an N-glycan-dependent manner. Catalyzes the first mannose trimming step, from Man9GlcNAc2 to Man8GlcNAc2 (PubMed:25092655). Extracts misfolded glycoproteins, but not glycoproteins undergoing productive folding, from the calnexin cycle.

    Aliases: bA4204.1 antibody, C20orf31 antibody, C20orf49 antibody, EDEM 2 antibody, EDEM2 antibody, EDEM2_HUMAN antibody, ER degradation enhancer mannosidase alpha like 2 antibody, ER degradation enhancing alpha mannosidase like 2 antibody, ER degradation enhancing alpha mannosidase like protein 2 antibody, ER degradation enhancing mannosidase like protein 2 antibody, ER degradation-enhancing alpha-mannosidase-like 2 antibody, FLJ10783 antibody, UNQ573/PRO1135 antibody

    UniProt
    Q9BV94
Vous êtes ici: